Drug interactions evaluation: An integrated part of risk assessment of therapeutics

This publication has 87 references indexed in Scilit:

• In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
  Drug Metabolism and Disposition, 2009
• Lopinavir–Ritonavir Dramatically Affects the Pharmacokinetics of Irinotecan in HIV Patients With Kaposi’s Sarcoma
  Clinical Pharmacology & Therapeutics, 2007
• Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity
  Clinics in Liver Disease, 2007
• STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
  Drug Metabolism and Disposition, 2006
• REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
  Annual Review of Pharmacology and Toxicology, 2006
• Physiological Approaches to the Prediction of Drug-Drug Interactions in Study Populations
  Current Drug Metabolism, 2003
• THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
  Drug Metabolism and Disposition, 2003
• Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance
  Current Medicinal Chemistry, 2002
• Cloning and Expression of Human UDP-Glucuronosyltransferase (UGT) 1A8
  Archives of Biochemistry and Biophysics, 1998
• Cephalosporin-Probenecid Drug Interactions
  Clinical Pharmacokinetics, 1993